Correlation Between Protokinetix and Regen BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protokinetix and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protokinetix and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protokinetix and Regen BioPharma, you can compare the effects of market volatilities on Protokinetix and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protokinetix with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protokinetix and Regen BioPharma.

Diversification Opportunities for Protokinetix and Regen BioPharma

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Protokinetix and Regen is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Protokinetix and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Protokinetix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protokinetix are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Protokinetix i.e., Protokinetix and Regen BioPharma go up and down completely randomly.

Pair Corralation between Protokinetix and Regen BioPharma

Given the investment horizon of 90 days Protokinetix is expected to generate 2.77 times less return on investment than Regen BioPharma. But when comparing it to its historical volatility, Protokinetix is 1.93 times less risky than Regen BioPharma. It trades about 0.04 of its potential returns per unit of risk. Regen BioPharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  94.00  in Regen BioPharma on September 4, 2024 and sell it today you would lose (88.49) from holding Regen BioPharma or give up 94.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Protokinetix  vs.  Regen BioPharma

 Performance 
       Timeline  
Protokinetix 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Protokinetix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Protokinetix showed solid returns over the last few months and may actually be approaching a breakup point.
Regen BioPharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Protokinetix and Regen BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protokinetix and Regen BioPharma

The main advantage of trading using opposite Protokinetix and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protokinetix position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.
The idea behind Protokinetix and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments